- Citations, last 5 years
- 67
- Works, last 5 years
- 20
- h-index
- 54
- Scientists listed
- 1
- Grants since 2016
- 4
Grants received
2024–2026 · research · R44
Development of CD4 TCR-engineered T cell immunotherapy in triple-negative breast cancer
Yicheng Wang · Onconova Therapeutics (United States) · funded by National Institutes of Health
2024–2027 · research · R44
Development of CD4 TCR-engineered T cell immunotherapy in triple-negative breast cancer
Yicheng Wang · Onconova Therapeutics (United States) · funded by National Institutes of Health
2022–2024 · research · R44
Development of a Therapeutic SAPNANO-ESO Vaccine for Prostate Cancer
Yicheng Wang · Onconova Therapeutics (United States) · funded by National Institutes of Health
2022–2026 · research · R44
Development of a Therapeutic SAPNANO-ESO Vaccine for Prostate Cancer
Yicheng Wang · Onconova Therapeutics (United States) · funded by National Institutes of Health
